Experience of an active regimen in the treatment of massive upper gastrointestinal haemorrhage.
Three-hundred and ninety-five cases of massive upper gastrointestinal haemorrhage were treated in the Surgical and Anaesthesiological Departments of the University Hospital in Linköping over a 5-year period. The mortality was 13%, or 10% when oesophageal varicosities are excluded. Results of a consistent policy concerning surveillance, diagnostic measures, and different forms of therapy are described. From the surgeon's point of view, emphasis is laid on the importance of endoscopy as a means of decreasing the number of exploratory gastroduodenotomies and increasing the proportion of patients in whom surgery is directed against a known source of bleeding. This leads to an enhancement of surgical expediency.
D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide; D000863:Antacids / Q000627:therapeutic use*; D004338:Drug Combinations; D005743:Gastrectomy; D005751:Gastric Lavage; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D005773:Gastroscopy; D006801:Humans; D008274:Magnesium; D008276:Magnesium Hydroxide; D008875:Middle Aged; D012008:Recurrence; D012151:Resuscitation; D014628:Vagotomy
D000863:Antacids; D004338:Drug Combinations; C036487:aluminium hydroxide, magnesium carbonate drug combination; D000536:Aluminum Hydroxide; D008274:Magnesium; D008276:Magnesium Hydroxide